The DOI matches its Crossref record.
Relaxin‐induced increased coronary flow through stimulation of nitric oxide production
Open accessAbstract
Relaxin (RLX) is a multifunctional hormone which, besides its role in pregnancy and parturition, has also been shown to influence the cardiovascular system. In this study, we investigated the effect of RLX on coronary flow of rat and guinea‐pig hearts, isolated and perfused in a Langendorff apparatus. RLX was either added to the perfusion fluid at a concentration of 5 × 10−9 M for a 20‐min perfusion, or given as a bolus into the aortic cannula at concentrations of 10−9 M, 5 × 10−9 M and 10−8 M dissolved in 1 ml of perfusion fluid. RLX, given either for a 20‐min perfusion or as a bolus in the aortic cannula to guinea‐pig and rat isolated hearts, increased the coronary flow and the amount of nitrite, a stable end‐product of nitric oxide (NO) metabolism, that appeared in the perfusates in a concentration‐dependent fashion. The increase in coronary flow and in nitrite in the perfusates induced by RLX was significantly reduced by pretreatment with the nitric oxide synthase (NOS) inhibitor, N G‐monomethyl‐L‐arginine (L‐NMMA, 10−4 M). The effects of RLX on coronary flow and nitrite amounts in the perfusates were compared with those induced by the endothelium‐dependent vasodilator agent, acetylcholine (ACh, 10−8 − 10−7 M), and by the endothelium‐independent vasodilator agent, sodium nitroprusside (SNP, 10−7‐10−6M). The results obtained show that RLX is more effective than ACh and SNP in increasing coronary flow. The results of this study show that RLX increases coronary flow through stimulation of NO production; hence this hormone should be regarded as a novel agent capable of improving myocardial perfusion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Relaxin’s Physiological Roles and Other Diverse Actions
Sherwood, O. D. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0013 · Cited by 543
Relaxin family peptides and their receptors
Bathgate, R. A. D., Halls, M. L., van der Westhuizen, E. T., Callander, G. E., Kocan, M., & Summers, R. J. (2013) · Physiological Reviews · doi:10.1152/physrev.00001.2012 · Cited by 534
Bathgate, R. A., Ivell, R., Sanborn, B. M., Sherwood, O. D., & Summers, R. J. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.9 · Cited by 335
Relaxin is a potent renal vasodilator in conscious rats
Danielson, L. A., Sherwood, O. D., & Conrad, K. P. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5630 · Cited by 274
Cardiovascular effects of relaxin: from basic science to clinical therapy
Du, X.-J., Bathgate, R. A. D., Samuel, C. S., Dart, A. M., & Summers, R. J. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.198 · Cited by 188
Metadata
- Authors
- Bani‐Sacchi, T., Bigazzi, M., Bani, D., Mannaioni, P. F., & Masini, E.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1995-09
- Volume
- 116
- Issue
- 1
- Pages
- 1589-1594
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1997835558
- Cited by
- 166
- References
- 0
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Relaxin‐induced increased coronary flow through stimulation of nitric oxide production. https://app.cochat.ai/papers/10.1111/j.1476-5381.1995.tb16377.x
- The paper
- Bani‐Sacchi, T., Bigazzi, M., Bani, D., Mannaioni, P. F., & Masini, E. (1995). Relaxin‐induced increased coronary flow through stimulation of nitric oxide production. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.1995.tb16377.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.